Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,266 | 1,167 | 92.5% |
| Travel and Lodging | $1,685 | 6 | 6.4% |
| Education | $296.53 | 13 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $3,068 | 151 | $0 (2020) |
| Abbott Laboratories | $2,426 | 171 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,379 | 141 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,941 | 14 | $0 (2021) |
| Medtronic, Inc. | $1,864 | 59 | $0 (2024) |
| ShockWave Medical, Inc | $1,847 | 31 | $0 (2024) |
| Boston Scientific Corporation | $1,612 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,546 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,245 | 74 | $0 (2024) |
| PFIZER INC. | $967.80 | 58 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,076 | 155 | Medtronic, Inc. ($825.69) |
| 2023 | $3,737 | 172 | ShockWave Medical, Inc ($586.14) |
| 2022 | $3,508 | 147 | Abbott Laboratories ($407.27) |
| 2021 | $2,205 | 117 | Abbott Laboratories ($374.77) |
| 2020 | $3,339 | 151 | Medtronic Vascular, Inc. ($1,160) |
| 2019 | $2,855 | 157 | Medtronic Vascular, Inc. ($750.79) |
| 2018 | $2,634 | 159 | Medtronic Vascular, Inc. ($791.73) |
| 2017 | $3,893 | 128 | Edwards Lifesciences Corporation ($1,708) |
All Payment Transactions
1,186 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $119.79 | General |
| Category: Vascular | ||||||
| 12/18/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/18/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: Medical Device | ||||||
| 12/18/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: CONTRAST AGENT | ||||||
| 12/16/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 12/14/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $173.01 | General |
| Category: Implant Cardio Defib - ICDs | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/10/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: Lithoplasty | ||||||
| 12/04/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Vascular | ||||||
| 12/04/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Vascular | ||||||
| 12/04/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: Vascular | ||||||
| 11/25/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
| 11/24/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: Medical Device | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $128.98 | General |
| Category: Lithoplasty | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $38.86 | General |
| Category: Implant Cardio Defib - ICDs | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 614 | 730 | $138,128 | $44,431 |
| 2022 | 12 | 867 | 983 | $171,633 | $53,910 |
| 2021 | 15 | 915 | 1,164 | $228,280 | $70,108 |
| 2020 | 16 | 945 | 1,228 | $220,552 | $67,816 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 208 | 301 | $67,809 | $24,278 | 35.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 20 | $13,340 | $3,558 | 26.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $12,264 | $3,363 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $9,359 | $3,019 | 32.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 33 | $7,458 | $2,887 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 45 | $6,644 | $2,240 | 33.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $7,104 | $2,209 | 31.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 157 | 161 | $5,658 | $1,472 | 26.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 14 | 14 | $2,436 | $684.66 | 28.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 45 | 47 | $4,935 | $430.67 | 8.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 14 | 14 | $672.00 | $174.87 | 26.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 14 | 14 | $448.00 | $115.33 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 225 | 319 | $73,051 | $25,479 | 34.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 38 | $16,644 | $5,499 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $12,950 | $4,320 | 33.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 26 | 27 | $14,769 | $4,127 | 27.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 73 | 73 | $12,702 | $3,656 | 28.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 15 | 15 | $10,005 | $2,478 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 40 | $6,160 | $2,086 | 33.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 26 | $5,876 | $2,040 | 34.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 179 | 186 | $6,696 | $1,702 | 25.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 81 | 81 | $3,888 | $1,169 | 30.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 81 | 81 | $2,592 | $790.92 | 30.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 57 | 60 | $6,300 | $562.40 | 8.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 205 | 300 | $68,700 | $25,255 | 36.8% |
About Dr. John Golding, MD
Dr. John Golding, MD is a Cardiovascular Disease healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255307575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Golding, MD has received a total of $26,247 in payments from pharmaceutical and medical device companies, with $4,076 received in 2024. These payments were reported across 1,186 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($24,266).
As a Medicare-enrolled provider, Golding has provided services to 3,341 Medicare beneficiaries, totaling 4,105 services with total Medicare billing of $236,265. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Chattanooga, TN
- Active Since 02/27/2006
- Last Updated 03/31/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1255307575
Products in Payments
- Resolute (Device) $2,675
- ENTRESTO (Drug) $1,874
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,742
- XARELTO (Drug) $1,546
- ELIQUIS (Drug) $1,058
- BRILINTA (Drug) $1,016
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $900.77
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $804.75
- Impella (Device) $633.04
- LEQVIO (Drug) $504.82
- AVEIR (Device) $500.31
- WATCHMAN Access System (Device) $386.68
- LifeVest (Device) $369.60
- JARDIANCE (Drug) $354.53
- Corlanor (Drug) $313.10
- COREVALVE EVOLUT R (Device) $288.98
- FLOWTRIEVER CATHETER, S (Device) $284.52
- CoreValve Evolut (Device) $270.98
- Repatha (Biological) $270.66
- FARXIGA (Drug) $267.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chattanooga
Dr. Harish Manyam, Md, MD
Cardiovascular Disease — Payments: $355,956
William Blalock, Md, MD
Cardiovascular Disease — Payments: $59,707
Newton Wiggins
Cardiovascular Disease — Payments: $48,698
Dr. Michael Allan, Md, MD
Cardiovascular Disease — Payments: $33,290
Walter Few, Md, MD
Cardiovascular Disease — Payments: $24,192
Augustus Mealor, Md, MD
Cardiovascular Disease — Payments: $19,638